Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,07 CNY | +0,43 % | +3,51 % | -11,62 % |
Resumen de negocios
China representa el 96,6% de las ventas netas.
Número de empleados: 3 121
Ventas por actividad
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Albumin - Imported Albumin
41,6
%
| 956 | 22,3 % | 2 734 | 41,6 % | +185,97 % |
Albumin - Self-produced Albumin
22,7
%
| 1 206 | 28,1 % | 1 489 | 22,7 % | +23,50 % |
Static C
20,0
%
| 1 067 | 24,9 % | 1 313 | 20,0 % | +23,05 % |
Other Blood Products
14,7
%
| 1 055 | 24,6 % | 968 | 14,7 % | -8,28 % |
Detection Device and Reagent
0,9
%
| - | - | 61 | 0,9 % | - |
Other
0,0
%
| 3 | 0,1 % | 1 | 0,0 % | -56,07 % |
Ventas por región
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 4 288 | 100,0 % | 6 567 | 100,0 % | +53,16 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jun Xu
CEO | Chief Executive Officer | 60 | 01/01/12 |
Le Qi Chen
DFI | Director of Finance/CFO | 37 | 26/10/21 |
Wei Bing Hu
CHM | Chairman | 60 | 03/03/03 |
Hong Qiu
IRC | Investor Relations Contact | - | - |
Ji Hui Chen
PRN | Corporate Officer/Principal | 58 | 01/05/04 |
Hui Lu
PRN | Corporate Officer/Principal | 49 | 01/05/09 |
Zheng Liu
SEC | Corporate Secretary | 54 | 27/04/07 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 68 | 20/05/20 | |
Yue Wen Zheng
BRD | Director/Board Member | 62 | 27/04/07 |
David Ian Bell
BRD | Director/Board Member | 70 | 20/05/20 |
Director/Board Member | 57 | 21/05/20 | |
Binh Hoang
BRD | Director/Board Member | 50 | 27/04/07 |
Jun Xu
CEO | Chief Executive Officer | 60 | 01/01/12 |
Wei Bing Hu
CHM | Chairman | 60 | 03/03/03 |
Yao Li
BRD | Director/Board Member | 61 | 27/04/07 |
Ling Peng
BRD | Director/Board Member | 45 | 20/05/20 |
Bing Yu Wang
BRD | Director/Board Member | 58 | 01/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 6 781 633 828 | 4 620 597 277 ( 68,13 %) | 136 153 070 ( 2,008 %) | 68,13 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
39 960 800 | 1.87% | 93 440 738 $ |
Información de la empresa
Shanghai RAAS Blood Products Co., Ltd.
2009 Wangyuan Road Biotechnology Park
201401, Shanghai
+
http://www.raas-corp.comVentas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-11,62 % | 6483,98 M | |
-2,86 % | 87,31 mil M | |
+3,95 % | 40,86 mil M | |
-21,94 % | 29,36 mil M | |
+53,87 % | 24,49 mil M | |
-5,41 % | 17,31 mil M | |
-44,23 % | 11,26 mil M | |
-17,60 % | 11,62 mil M | |
-13,96 % | 11,31 mil M | |
+4,87 % | 8311,69 M |
- Bolsa de valores
- Acciones
- Acción 002252
- Empresa Shanghai RAAS Blood Products Co., Ltd.